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Background: Thoracic endovascular aortic repair (TEVAR) is becoming increasingly popular due to reduced
perioperative morbidity and mortality compared with open surgical repair. However, complications can occur when
the left subclavian artery is involved. When performing TEVAR with left carotid-subclavian artery bypass the stent graft
will extend to the left common carotid artery. We herein present the case of a patient with a type B aortic dissection
with an acute intramural hematoma. Chylothorax was noted after TEVAR with left carotid-subclavian artery bypass.
Case report: A 66-year-old female with descending aortic dissection that was treated conservatively developed the
sudden onset of back pain. Aortic computed tomography (CT) showed a type B intramural aortic dissection. TEVAR with
left carotid-subclavian artery bypass was performed. Left chylothorax was noted after surgery with drainage of up to
1000 mL per day. Conservative management was ineffective. Thoracoscopic ligation of the thoracic duct was performed
with resolution of the chyle leakage.
Conclusion: Chylothorax can occur after TEVAR with carotid-subclavian artery bypass and likely results from thoracic
duct injury. When conservative treatments fail, ligation of the thoracic duct cephalad to aortic hiatus can resolve the
chyle leakage.Background
Thoracic endovascular aortic repair (TEVAR) is becom-
ing increasingly popular due to reduced perioperative
morbidity and mortality compared with open surgical re-
pair [1]. We herein present the case of a patient with a
type B aortic dissection with an acute intramural
hematoma. Left chylothorax was noted after TEVAR
with left carotid-subclavian artery bypass.Case presentation
A 66-year-old female developed a descending aortic dis-
section and was treated conservatively with medical
therapy because there were no complications such as
splanchnic ischemia, renal insufficiency, lower extremity
ischemia, or focal neurologic deficits. One month later
she was admitted via our emergency department (ED)
because of recurrent severe back pain. Aortic computed* Correspondence: maskever@pchome.com.tw
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unless otherwise stated.tomography (CT) showed a type B aortic dissection with
intramural hematoma and false lumen expansion (Figure 1).
She underwent TEVAR. Left carotid-subclavian artery by-
pass was performed by exploration from left low neck for
left subclavian artery coverage (Figure 2A). After surgery,
she resumed oral intake and increased left pleural drainage
of a milky fluid was noted on postoperative day 2. Aortic
CT on postoperative day 4 revealed no endoleak or
thrombosis. Persistent pleural drainage of a milky appear-
ing fluid of more than 1000 mL per day continued. The
pleural fluid triglyceride concentration was 227 mg/dL.
Left chylothorax resulting from disruption of the thoracic
duct during the left carotid-subclavian artery bypass was
suspected. Conservative medical treatment of nothing per
oral (NPO) and administration of total parenteral nutri-
tion (TPN) failed to reduce the amount of drainage.
Therefore, surgical ligation of the thoracic duct was
planned at postoperative day 30. After induction of gen-
eral anesthesia, the right lung was deflated, and 3 trocar
sleeves were inserted at lateral ninth, anterior lateral sev-
enth, and anterior lateral fifth intercostal spaces. The pul-
monary ligament was transected, and the lung was
retracted. The parietal pleura was incised along the distal. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Transverse CT scan showed hematoma formation in the descending aorta. (A-C) One month before admission, descending aortic
dissection was diagnosed and the patient was treated with medical therapy. (D-F) At admission, as compared to the prior CT scan an intramural
hematoma with false lumen was noted.
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should be found between aorta and azygos vein. Careful
dissection exposed the thoracic duct as near as possible to
diaphragm, which was then ligated (Figure 2B). Her recov-
ery was uneventful, and the left Jackson-Pratt drain was
removed on postoperative day 5. At the 3-month follow-
up, chylothorax was not recurrent (Figure 2C).Figure 2 Images in operation and following. (A) The left subclavian artery
artery. A coil was placed in the proximal left subclavian artery. A right to left c
was performed to dissect and ligate the thoracic duct (arrow). (C) No pleuralDiscussion
TEVAR was developed to address degenerative aneu-
rysmal disease including aortic dissection, aortic transec-
tion, intramural hematoma, and penetrating aortic ulcer
[1,2]. When treating proximal lesions, the left subclavian
artery will be covered and the stent graft will extend to the
left common carotid artery [3,4]. The principal brancheswas covered, and the stent graft extended to the left common carotid
arotid–carotid bypass was performed (arrow). (B) Thoracoscopic surgery
effusion was noted at the 3-month follow-up.
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trunk, which gives rise to the ascending and transverse
cervical arteries, the suprascapular artery, and the inferior
thyroid artery; the costocervical trunk; the internal mam-
mary artery; and the vertebral artery. Thus, there are
many potential complications following subclavian artery
occlusion including upper extremity ischemia, stroke,
spinal cord ischemia, and myocardial ischemia [3-7].
Carotid-subclavian artery bypass was designed to resolve
subclavian artery occlusion. Unfortunately, many compli-
cations following carotid-subclavian artery bypass can
occur including vocal cord paralysis, phrenic nerve palsy,
vagus nerve injury, bleeding, thoracic duct injury, lympho-
cele, and sympathetic nerve injury resulting in Horner
syndrome [7-10].
Chylothorax results from disruption or obstruction of
the thoracic duct and subsequent leakage of chyle
(lymphatic fluid of intestinal origin) into the pleural
space [11]. The pleural effusion typically has a high tri-
glyceride concentration, and often a turbid or milky
white appearance. The etiologies of chylothorax can be
categorized as nontraumatic or traumatic [12,13]. Malig-
nancy is the leading cause of nontraumatic chylothorax.
Surgical procedures in the area of the thoracic duct or
nearby structures can result in disruption of the thoracic
duct or shearing of lymphatic tributaries, and account
for the majority of traumatic chylothorax cases.
The thoracic duct is the largest lymph vessel, and ex-
tends from the second lumbar vertebra to the root of
the neck. It enters the thorax through the aortic opening
of the diaphragm between the aorta and the azygos vein.
At the level of the fifth thoracic vertebra, the thoracic
duct inclines towards the left side to enter the superior
mediastinum and ascends behind the aortic arch and the
thoracic part of the left subclavian artery, between the
left side of the esophagus and the left pleura, to the thor-
acic inlet. In the neck, the arch of the thoracic duct rises
3 or 4 cm (up to 6 cm) above the clavicle and curves an-
terior to the vertebral artery and vein, the left sympa-
thetic trunk, the thyrocervical artery or its branches, the
left phrenic nerve, and the medial border of scalenus an-
terior. It then passes posterior to the left common ca-
rotid artery, vagus nerve, and internal jugular vein, and
finally ends by opening into the angle of the junction of
the left subclavian vein and the internal jugular vein.
Shimado and Sato reported four types of thoracic duct
terminations [14]. Type A (38%) terminated at the ven-
ous angle, type B (27%) at the terminal end of the in-
ternal jugular vein, type C (28%) at the terminal end of
the external jugular vein, and type D (7%) was described
as a complex branching pattern. Each type was further
subdivided depending upon the number of terminal
branches, some of which drained directly into the sub-
clavian vein. The termination is usually (87.5 to 100% ofthe time) within 1 cm of the venous angle [15]. Langford
and Daudia reported 21 ducts (87.5%) terminated as a
single vessel, two ducts (8.33%) showed a bifid termin-
ation, and one duct (4.2%) had three terminal branches.
Five thoracic ducts (20.8%) showed branching and re-
anastamosing patterns prior to their termination, irre-
spective of the number of terminal branches [16]. The
presence of such complex patterns is an additional risk
factor for iatrogenic trauma, and a potent source of con-
fusion when faced with the surgical management of a
chyle leak.
When TEVAR is performed at the proximal portion of
the aorta, as in our patient, the left subclavian artery will
be covered by the membrane portion of the stent graft
and the subclavian artery will be occluded. Left carotid-
subclavian artery bypass is performed at the same time.
The thoracic duct drains chyle into the blood stream via
the left subclavian vein. It is possible to injury the thor-
acic duct when performing the bypass, to result in chyle
leakage. We believe this is what occurred in our patient.
For patients with traumatic chylothorax, initial conser-
vative management rather than surgical intervention is
recommended. Conservative management includes chest
tube drainage, and either bowel rest with total parenteral
nutrition (TPN) or a high protein-reduced fat diet with
medium chain triglyceride (MCT) supplementation [17,18].
Attention to fluid and electrolyte management, nutrition,
and the daily volume of pleural drainage are necessary. If
the amount of chylous fluid drainage is >1 L per day
through the chest tube, early thoracic duct ligation is rec-
ommended. Patients draining more than 1 L/day are un-
likely to respond to conservative therapy, and usually
require surgical intervention within 5 to 7 days [19]. In
contrast, patients with < 500 mL of chest tube drainage in
the first 24 hours after cessation of oral intake and initi-
ation of TPN tend to improve with conservative manage-
ment [20]. If pleural drainage continues after 14 days of
conservative therapy, some studies recommand thoracic
duct ligation as a longer duration of conservative therapy
is associated with nutritional depletion and high mortality
rates [21,22].
The advent of thoracoscopic surgery over the last dec-
ade has changed the approach to the management of a
number of chest diseases. Because of fewer and smaller
incisions, thoracoscopic surgery is associated with less
pain, faster postoperative recovery, shortened hospital
stay, and decreased long-term morbidity. Intrathoracic
postoperative adhesions are milder with thoracoscopic
surgery compared to open thoracotomy. Thoracoscopic
surgery has the advantage of shortened recuperation
time and decreased blood loss [23-25]. Because of the
benefits associated with thoracoscopic surgery, we uti-
lized a thoracoscopic approach and the thoracic duct
was reached through the right pleural cavity, and ligated
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was no chylothorax recurrence in our patient during the
3 months follow-up.
Conclusion
Subclavian revascularization procedures can be per-
formed with relatively low risk, and complications are
rare. Chylothorax can occur after TEVAR with carotid-
subclavian artery bypass from neck exploration and
likely results from thoracic duct injury. When conserva-
tive treatments fail, ligation of the thoracic duct cepha-
lad to aortic hiatus by thoracoscopic surgery can resolve
the chyle leakage.
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